Hinge Health is trading 4.05% higher at $90.89, with no clear company-specific catalyst identified for August 31, 2026.
- Its latest major developments are August 4 second-quarter results and the planned $105 million Cylinder Health acquisition, both already public before this move.
- Broader markets are modestly lower, so current evidence does not establish a direct macro or company explanation for the gain.